Narayana Hrudayalaya Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: April 2, 2025, 9:26 pm

Market Cap	34,487 Cr.
Current Price	1,687
High / Low	1,725/1,080
Stock P/E	44.0
Book Value	157
Dividend Yield	0.24 %
ROCE	26.5 %
ROE	31.4 %
Face Value	10.0
PEG Ratio	0.40

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Narayana Hrudayalaya Ltd

Competitors of Narayana Hrudayalaya Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Narayana Hrudayalaya Ltd	34,487 Cr.	1,687	1,725/1,080	44.0	157	0.24 %	26.5 %	31.4 %	10.0
Lotus Eye Hospital & Institute Ltd	140 Cr.	68.0	91.0/52.4	275	28.9	0.00 %	7.07 %	4.97 %	10.0
Industry Average	17,313.50 Cr	877.50		159.50	92.95	0.12%	16.79%	18.19%	10.00

All Competitor Stocks of Narayana Hrudayalaya Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	960	941	1,033	1,142	1,128	1,222	1,233	1,305	1,204	1,279	1,341	1,400	1,367
Expenses	787	768	842	898	874	946	963	997	925	985	1,037	1,092	1,060
Operating Profit	173	172	192	244	254	276	271	308	279	295	304	308	307
OPM %	18%	18%	19%	21%	23%	23%	22%	24%	23%	23%	23%	22%	22%
Other Income	7	10	8	31	12	15	15	18	18	24	23	24	18
Interest	16	16	15	15	19	21	21	23	25	28	34	35	37
Depreciation	46	47	47	49	57	56	59	55	63	65	62	65	70
Profit before tax	117	119	137	211	190	214	206	248	209	226	232	232	219
Tax %	17%	42%	19%	20%	19%	19%	11%	9%	10%	15%	13%	14%	12%
Net Profit	98	69	111	169	154	173	184	227	188	191	202	199	193
EPS in Rs	4.77	3.37	5.41	8.26	7.52	8.47	9.00	11.09	9.20	9.33	9.85	9.72	9.44

Last Updated: February 28, 2025, 6:14 pm

Below is a detailed analysis of the quarterly data for Narayana Hrudayalaya Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is ₹1,367.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,400.00 Cr. (Sep 2024) to ₹1,367.00 Cr., marking a decrease of 33.00 Cr..
For Expenses, as of Dec 2024, the value is ₹1,060.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,092.00 Cr. (Sep 2024) to ₹1,060.00 Cr., marking a decrease of 32.00 Cr..
For Operating Profit, as of Dec 2024, the value is ₹307.00 Cr.. The value appears to be declining and may need further review. It has decreased from 308.00 Cr. (Sep 2024) to ₹307.00 Cr., marking a decrease of 1.00 Cr..
For OPM %, as of Dec 2024, the value is 22.00%. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 22.00%.
For Other Income, as of Dec 2024, the value is ₹18.00 Cr.. The value appears to be declining and may need further review. It has decreased from 24.00 Cr. (Sep 2024) to ₹18.00 Cr., marking a decrease of 6.00 Cr..
For Interest, as of Dec 2024, the value is ₹37.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 35.00 Cr. (Sep 2024) to ₹37.00 Cr., marking an increase of 2.00 Cr..
For Depreciation, as of Dec 2024, the value is ₹70.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 65.00 Cr. (Sep 2024) to ₹70.00 Cr., marking an increase of 5.00 Cr..
For Profit before tax, as of Dec 2024, the value is ₹219.00 Cr.. The value appears to be declining and may need further review. It has decreased from 232.00 Cr. (Sep 2024) to ₹219.00 Cr., marking a decrease of 13.00 Cr..
For Tax %, as of Dec 2024, the value is 12.00%. The value appears to be improving (decreasing) as expected. It has decreased from 14.00% (Sep 2024) to 12.00%, marking a decrease of 2.00%.
For Net Profit, as of Dec 2024, the value is ₹193.00 Cr.. The value appears to be declining and may need further review. It has decreased from 199.00 Cr. (Sep 2024) to ₹193.00 Cr., marking a decrease of 6.00 Cr..
For EPS in Rs, as of Dec 2024, the value is 9.44. The value appears to be declining and may need further review. It has decreased from 9.72 (Sep 2024) to 9.44, marking a decrease of 0.28.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 7, 2025, 7:24 pm

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	839	1,095	1,364	1,614	1,878	2,281	2,861	3,128	2,583	3,701	4,525	5,018	5,387
Expenses	769	989	1,236	1,434	1,642	2,064	2,566	2,694	2,394	3,038	3,538	3,845	4,173
Operating Profit	70	106	128	180	236	217	295	434	189	664	987	1,173	1,214
OPM %	8%	10%	9%	11%	13%	10%	10%	14%	7%	18%	22%	23%	23%
Other Income	28	39	6	-19	7	18	16	7	21	26	59	70	89
Interest	19	31	45	33	28	55	81	94	82	76	84	112	134
Depreciation	46	57	68	76	80	100	137	186	184	183	210	242	262
Profit before tax	34	57	21	51	135	80	93	161	-56	430	752	889	908
Tax %	29%	38%	71%	59%	39%	36%	37%	26%	-75%	20%	19%	11%
Net Profit	24	29	-19	21	83	51	59	119	-14	342	607	790	784
EPS in Rs	762.14	974.49	-0.84	1.04	4.06	2.51	2.90	5.82	-0.70	16.73	29.67	38.62	38.34
Dividend Payout %	0%	0%	0%	0%	0%	0%	35%	17%	0%	6%	8%	10%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	20.83%	-165.52%	210.53%	295.24%	-38.55%	15.69%	101.69%	-111.76%	2542.86%	77.49%	30.15%
Change in YoY Net Profit Growth (%)	0.00%	-186.35%	376.04%	84.71%	-333.79%	54.24%	86.01%	-213.46%	2654.62%	-2465.37%	-47.34%

Narayana Hrudayalaya Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	16%
5 Years:	12%
3 Years:	25%
TTM:	9%

Compounded Profit Growth
10 Years:	51%
5 Years:	68%
3 Years:	365%
TTM:	2%

Stock Price CAGR
10 Years:	%
5 Years:	44%
3 Years:	31%
1 Year:	29%

Return on Equity
10 Years:	17%
5 Years:	24%
3 Years:	31%
Last Year:	31%

Last Updated: Unknown

Balance Sheet

Last Updated: November 14, 2024, 8:00 pm

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	0.33	0.33	200	204	204	204	204	204	204	204	204	204	204
Reserves	547	580	568	672	759	831	877	932	916	1,284	1,927	2,679	3,001
Borrowings	256	333	362	258	217	802	813	952	826	723	884	1,627	1,703
Other Liabilities	160	242	241	424	468	692	746	813	833	931	1,155	1,123	1,334
Total Liabilities	963	1,156	1,371	1,557	1,648	2,529	2,640	2,901	2,779	3,143	4,170	5,633	6,243
Fixed Assets	620	738	913	1,054	1,082	1,848	1,838	2,092	1,961	1,980	2,336	2,651	3,068
CWIP	44	20	20	14	53	35	56	12	20	67	259	514	737
Investments	7	51	52	87	96	9	17	86	120	132	252	844	911
Other Assets	292	346	385	402	417	637	729	711	678	964	1,323	1,624	1,528
Total Assets	963	1,156	1,371	1,557	1,648	2,529	2,640	2,901	2,779	3,143	4,170	5,633	6,243

Below is a detailed analysis of the balance sheet data for Narayana Hrudayalaya Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹204.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 204.00 Cr..
For Reserves, as of Sep 2024, the value is ₹3,001.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,679.00 Cr. (Mar 2024) to ₹3,001.00 Cr., marking an increase of 322.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹1,703.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1,627.00 Cr. (Mar 2024) to ₹1,703.00 Cr., marking an increase of 76.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹1,334.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,123.00 Cr. (Mar 2024) to ₹1,334.00 Cr., marking an increase of 211.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹6,243.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5,633.00 Cr. (Mar 2024) to ₹6,243.00 Cr., marking an increase of 610.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹3,068.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,651.00 Cr. (Mar 2024) to ₹3,068.00 Cr., marking an increase of 417.00 Cr..
For CWIP, as of Sep 2024, the value is ₹737.00 Cr.. The value appears strong and on an upward trend. It has increased from 514.00 Cr. (Mar 2024) to ₹737.00 Cr., marking an increase of 223.00 Cr..
For Investments, as of Sep 2024, the value is ₹911.00 Cr.. The value appears strong and on an upward trend. It has increased from 844.00 Cr. (Mar 2024) to ₹911.00 Cr., marking an increase of 67.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹1,528.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,624.00 Cr. (Mar 2024) to ₹1,528.00 Cr., marking a decrease of 96.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹6,243.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,633.00 Cr. (Mar 2024) to ₹6,243.00 Cr., marking an increase of 610.00 Cr..

Notably, the Reserves (₹3,001.00 Cr.) exceed the Borrowings (1,703.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	45	110	77	174	219	182	279	443	304	485	1,085	1,067
Cash from Investing Activity +	-147	-168	-223	-150	-146	-520	-162	-189	-113	-267	-1,176	-1,458
Cash from Financing Activity +	108	57	140	18	-45	315	-27	-247	-194	-159	88	488
Net Cash Flow	6	-1	-6	42	28	-22	89	7	-2	59	-4	97

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-186.00	-227.00	-234.00	-78.00	19.00	-585.00	-518.00	-518.00	-637.00	-59.00	103.00	0.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	40	45	38	34	30	45	34	31	39	43	35	31
Inventory Days	60	64	56	48	45	56	48	35	32	30	31	42
Days Payable	121	198	146	152	173	200	177	177	221	180	224	205
Cash Conversion Cycle	-21	-90	-51	-70	-98	-100	-95	-111	-150	-108	-158	-132
Working Capital Days	10	2	-3	-2	-9	-4	-8	-17	-17	-0	-11	-9
ROCE %	5%	8%	7%	9%	14%	9%	9%	14%	2%	25%	32%	27%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	63.85%	63.85%	63.85%	63.85%	63.85%	63.85%	63.85%	63.85%	63.85%	63.85%	63.85%	63.85%
FIIs	10.64%	10.03%	9.55%	10.24%	10.36%	11.10%	11.59%	11.51%	10.91%	10.01%	9.69%	9.45%
DIIs	18.34%	17.85%	16.62%	14.58%	14.14%	11.95%	10.89%	10.23%	9.51%	8.22%	7.90%	8.68%
Government	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	0.01%	0.00%	0.00%
Public	6.47%	7.59%	9.28%	10.70%	11.01%	12.45%	13.05%	13.78%	15.12%	17.29%	17.94%	17.39%
Others	0.70%	0.69%	0.69%	0.63%	0.63%	0.63%	0.62%	0.62%	0.62%	0.62%	0.62%	0.62%
No. of Shareholders	52,747	65,173	68,130	73,157	75,370	86,631	1,02,994	1,20,506	1,38,052	1,60,686	1,78,356	1,77,792

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
Axis Small Cap Fund	6,641,167	4.54	813.94	200,000	2025-04-02	3220.58%
Axis Flexi Cap Fund	1,971,606	2.17	241.64	200,000	2025-04-02	885.8%
Nippon India Pharma Fund	1,849,571	3.65	226.68	200,000	2025-04-02	824.79%
DSP Small Cap Fund	1,801,189	1.69	220.75	200,000	2025-04-02	800.59%
Nippon India Multi Cap Fund	927,845	0.5	113.72	200,000	2025-04-02	363.92%
Axis Multicap Fund	907,694	2.41	111.25	200,000	2025-04-02	353.85%
HDFC ELSS Tax Saver Fund	300,000	0.3	36.77	200,000	2025-04-02	50%
UTI Small Cap Fund	289,601	1.03	35.49	200,000	2025-04-02	44.8%
Bandhan Flexi Cap Fund	255,143	0.49	31.27	200,000	2025-04-02	27.57%
Baroda BNP Paribas Small Cap Fund	200,000	2.01	24.51	200,000	2025-04-02	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	38.86	29.85	16.85	-0.70	5.86
Diluted EPS (Rs.)	38.86	29.85	16.85	-0.70	5.86
Cash EPS (Rs.)	50.49	39.97	26.14	8.62	15.08
Book Value[Excl.RevalReserv]/Share (Rs.)	141.18	104.35	72.88	54.84	55.61
Book Value[Incl.RevalReserv]/Share (Rs.)	141.18	104.35	72.88	54.84	55.61
Revenue From Operations / Share (Rs.)	245.56	221.41	181.12	126.36	153.05
PBDIT / Share (Rs.)	60.07	50.46	33.67	10.29	21.86
PBIT / Share (Rs.)	48.22	40.19	24.69	1.31	12.77
PBT / Share (Rs.)	43.48	36.79	21.45	-2.41	8.06
Net Profit / Share (Rs.)	38.64	29.69	17.16	-0.36	5.99
NP After MI And SOA / Share (Rs.)	38.62	29.66	16.73	-0.69	5.82
PBDIT Margin (%)	24.46	22.79	18.59	8.14	14.28
PBIT Margin (%)	19.63	18.14	13.63	1.03	8.34
PBT Margin (%)	17.70	16.61	11.84	-1.90	5.26
Net Profit Margin (%)	15.73	13.40	9.47	-0.28	3.91
NP After MI And SOA Margin (%)	15.72	13.39	9.23	-0.55	3.80
Return on Networth / Equity (%)	27.36	28.44	22.96	-1.27	10.46
Return on Capital Employeed (%)	21.82	25.86	21.46	1.29	11.38
Return On Assets (%)	14.03	14.56	10.92	-0.51	4.11
Long Term Debt / Equity (X)	0.41	0.29	0.29	0.44	0.54
Total Debt / Equity (X)	0.50	0.35	0.36	0.46	0.55
Asset Turnover Ratio (%)	1.03	1.00	0.95	0.66	0.92
Current Ratio (X)	1.75	1.31	1.17	0.94	0.97
Quick Ratio (X)	1.65	1.24	1.09	0.87	0.87
Dividend Payout Ratio (NP) (%)	6.43	3.34	0.00	0.00	41.18
Dividend Payout Ratio (CP) (%)	4.92	2.48	0.00	0.00	16.07
Earning Retention Ratio (%)	93.57	96.66	0.00	0.00	58.82
Cash Earning Retention Ratio (%)	95.08	97.52	0.00	0.00	83.93
Interest Coverage Ratio (X)	12.67	14.85	10.38	2.77	5.24
Interest Coverage Ratio (Post Tax) (X)	9.15	9.74	6.29	0.90	2.56
Enterprise Value (Cr.)	27191.98	16202.98	15629.99	8692.93	5572.05
EV / Net Operating Revenue (X)	5.42	3.58	4.22	3.37	1.78
EV / EBITDA (X)	22.15	15.71	22.72	41.34	12.47
MarketCap / Net Operating Revenue (X)	5.21	3.50	4.12	3.21	1.62
Retention Ratios (%)	93.56	96.65	0.00	0.00	58.81
Price / BV (X)	9.07	7.42	10.25	7.41	4.45
Price / Net Operating Revenue (X)	5.21	3.50	4.12	3.21	1.62
EarningsYield	0.03	0.03	0.02	0.00	0.02

After reviewing the key financial ratios for Narayana Hrudayalaya Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 38.86. This value is within the healthy range. It has increased from 29.85 (Mar 23) to 38.86, marking an increase of 9.01.
For Diluted EPS (Rs.), as of Mar 24, the value is 38.86. This value is within the healthy range. It has increased from 29.85 (Mar 23) to 38.86, marking an increase of 9.01.
For Cash EPS (Rs.), as of Mar 24, the value is 50.49. This value is within the healthy range. It has increased from 39.97 (Mar 23) to 50.49, marking an increase of 10.52.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 141.18. It has increased from 104.35 (Mar 23) to 141.18, marking an increase of 36.83.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 141.18. It has increased from 104.35 (Mar 23) to 141.18, marking an increase of 36.83.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 245.56. It has increased from 221.41 (Mar 23) to 245.56, marking an increase of 24.15.
For PBDIT / Share (Rs.), as of Mar 24, the value is 60.07. This value is within the healthy range. It has increased from 50.46 (Mar 23) to 60.07, marking an increase of 9.61.
For PBIT / Share (Rs.), as of Mar 24, the value is 48.22. This value is within the healthy range. It has increased from 40.19 (Mar 23) to 48.22, marking an increase of 8.03.
For PBT / Share (Rs.), as of Mar 24, the value is 43.48. This value is within the healthy range. It has increased from 36.79 (Mar 23) to 43.48, marking an increase of 6.69.
For Net Profit / Share (Rs.), as of Mar 24, the value is 38.64. This value is within the healthy range. It has increased from 29.69 (Mar 23) to 38.64, marking an increase of 8.95.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 38.62. This value is within the healthy range. It has increased from 29.66 (Mar 23) to 38.62, marking an increase of 8.96.
For PBDIT Margin (%), as of Mar 24, the value is 24.46. This value is within the healthy range. It has increased from 22.79 (Mar 23) to 24.46, marking an increase of 1.67.
For PBIT Margin (%), as of Mar 24, the value is 19.63. This value is within the healthy range. It has increased from 18.14 (Mar 23) to 19.63, marking an increase of 1.49.
For PBT Margin (%), as of Mar 24, the value is 17.70. This value is within the healthy range. It has increased from 16.61 (Mar 23) to 17.70, marking an increase of 1.09.
For Net Profit Margin (%), as of Mar 24, the value is 15.73. This value exceeds the healthy maximum of 10. It has increased from 13.40 (Mar 23) to 15.73, marking an increase of 2.33.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 15.72. This value is within the healthy range. It has increased from 13.39 (Mar 23) to 15.72, marking an increase of 2.33.
For Return on Networth / Equity (%), as of Mar 24, the value is 27.36. This value is within the healthy range. It has decreased from 28.44 (Mar 23) to 27.36, marking a decrease of 1.08.
For Return on Capital Employeed (%), as of Mar 24, the value is 21.82. This value is within the healthy range. It has decreased from 25.86 (Mar 23) to 21.82, marking a decrease of 4.04.
For Return On Assets (%), as of Mar 24, the value is 14.03. This value is within the healthy range. It has decreased from 14.56 (Mar 23) to 14.03, marking a decrease of 0.53.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.41. This value is within the healthy range. It has increased from 0.29 (Mar 23) to 0.41, marking an increase of 0.12.
For Total Debt / Equity (X), as of Mar 24, the value is 0.50. This value is within the healthy range. It has increased from 0.35 (Mar 23) to 0.50, marking an increase of 0.15.
For Asset Turnover Ratio (%), as of Mar 24, the value is 1.03. It has increased from 1.00 (Mar 23) to 1.03, marking an increase of 0.03.
For Current Ratio (X), as of Mar 24, the value is 1.75. This value is within the healthy range. It has increased from 1.31 (Mar 23) to 1.75, marking an increase of 0.44.
For Quick Ratio (X), as of Mar 24, the value is 1.65. This value is within the healthy range. It has increased from 1.24 (Mar 23) to 1.65, marking an increase of 0.41.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 6.43. This value is below the healthy minimum of 20. It has increased from 3.34 (Mar 23) to 6.43, marking an increase of 3.09.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 4.92. This value is below the healthy minimum of 20. It has increased from 2.48 (Mar 23) to 4.92, marking an increase of 2.44.
For Earning Retention Ratio (%), as of Mar 24, the value is 93.57. This value exceeds the healthy maximum of 70. It has decreased from 96.66 (Mar 23) to 93.57, marking a decrease of 3.09.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 95.08. This value exceeds the healthy maximum of 70. It has decreased from 97.52 (Mar 23) to 95.08, marking a decrease of 2.44.
For Interest Coverage Ratio (X), as of Mar 24, the value is 12.67. This value is within the healthy range. It has decreased from 14.85 (Mar 23) to 12.67, marking a decrease of 2.18.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 9.15. This value is within the healthy range. It has decreased from 9.74 (Mar 23) to 9.15, marking a decrease of 0.59.
For Enterprise Value (Cr.), as of Mar 24, the value is 27,191.98. It has increased from 16,202.98 (Mar 23) to 27,191.98, marking an increase of 10,989.00.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 5.42. This value exceeds the healthy maximum of 3. It has increased from 3.58 (Mar 23) to 5.42, marking an increase of 1.84.
For EV / EBITDA (X), as of Mar 24, the value is 22.15. This value exceeds the healthy maximum of 15. It has increased from 15.71 (Mar 23) to 22.15, marking an increase of 6.44.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 5.21. This value exceeds the healthy maximum of 3. It has increased from 3.50 (Mar 23) to 5.21, marking an increase of 1.71.
For Retention Ratios (%), as of Mar 24, the value is 93.56. This value exceeds the healthy maximum of 70. It has decreased from 96.65 (Mar 23) to 93.56, marking a decrease of 3.09.
For Price / BV (X), as of Mar 24, the value is 9.07. This value exceeds the healthy maximum of 3. It has increased from 7.42 (Mar 23) to 9.07, marking an increase of 1.65.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 5.21. This value exceeds the healthy maximum of 3. It has increased from 3.50 (Mar 23) to 5.21, marking an increase of 1.71.
For EarningsYield, as of Mar 24, the value is 0.03. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Narayana Hrudayalaya Ltd as of April 4, 2025 is: 1,739.45

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of April 4, 2025, Narayana Hrudayalaya Ltd is Undervalued by 3.11% compared to the current share price 1,687.00

Intrinsic Value of Narayana Hrudayalaya Ltd as of April 4, 2025 is: 3,638.40

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of April 4, 2025, Narayana Hrudayalaya Ltd is Undervalued by 115.67% compared to the current share price 1,687.00

Last 5 Year EPS CAGR: 109.17%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a low average Working Capital Days of -5.67, which is a positive sign. The stock has a low average Cash Conversion Cycle of -98.67, which is a positive sign. The company has higher reserves (1,197.92 cr) compared to borrowings (750.46 cr), indicating strong financial stability. The company has shown consistent growth in sales (66.85 cr) and profit (273.46 cr) over the years.	The stock has a low average ROCE of 13.42%, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Narayana Hrudayalaya Ltd:
1. Net Profit Margin: 15.73%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 21.82% (Industry Average ROCE: 16.79%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 27.36% (Industry Average ROE: 18.19%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 9.15
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1.65
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 44 (Industry average Stock P/E: 159.5)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.5
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Narayana Hrudayalaya Ltd. is a Public Limited Listed company incorporated on 19/07/2000 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is L85110KA2000PLC027497 and registration number is 027497. Currently Company is involved in the business activities of Hospital activities. Company's Total Operating Revenue is Rs. 3265.70 Cr. and Equity Capital is Rs. 204.36 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Hospitals & Medical Services	No.258/A, Bommasandra Industrial Area, Bengaluru Karnataka 560099	investorrelations@narayanahealth.org http://www.narayanahealth.org

Management
Name	Position Held
Dr. Devi Prasad Shetty	Chairman & Wholetime Director
Mr. Viren Prasad Shetty	Exe.Vice Chairman & Whole Time Director
Dr. Emmanuel Rupert	Managing Director & Group CEO
Dr. Kiran Mazumdar Shaw	Non Executive Director
Dr. Anesh Shetty	Addnl. & Non Exe.Director
Ms. Nivruti Rai	Addnl. & Non Exe.Director
Ms. Terri Smith Bresenham	Independent Director
Mr. Shankar Arunachalam	Independent Director
Dr. Nachiket Mor	Independent Director
Mr. Naveen Tewari	Independent Director

FAQ

What is the intrinsic value of Narayana Hrudayalaya Ltd?

Narayana Hrudayalaya Ltd's intrinsic value (as of 04 April 2025) is ₹1739.45 — 3.11% higher the current market price of ₹1,687.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 34,487 Cr. market cap, FY2025-2026 high/low of ₹1,725/1,080, reserves of 3,001 Cr, and liabilities of 6,243 Cr.

What is the Market Cap of Narayana Hrudayalaya Ltd?

The Market Cap of Narayana Hrudayalaya Ltd is 34,487 Cr..

What is the current Stock Price of Narayana Hrudayalaya Ltd as on 04 April 2025?

The current stock price of Narayana Hrudayalaya Ltd as on 04 April 2025 is 1,687.

What is the High / Low of Narayana Hrudayalaya Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Narayana Hrudayalaya Ltd stocks is ₹1,725/1,080.

What is the Stock P/E of Narayana Hrudayalaya Ltd?

The Stock P/E of Narayana Hrudayalaya Ltd is 44.0.

What is the Book Value of Narayana Hrudayalaya Ltd?

The Book Value of Narayana Hrudayalaya Ltd is 157.

What is the Dividend Yield of Narayana Hrudayalaya Ltd?

The Dividend Yield of Narayana Hrudayalaya Ltd is 0.24 %.

What is the ROCE of Narayana Hrudayalaya Ltd?

The ROCE of Narayana Hrudayalaya Ltd is 26.5 %.

What is the ROE of Narayana Hrudayalaya Ltd?

The ROE of Narayana Hrudayalaya Ltd is 31.4 %.

What is the Face Value of Narayana Hrudayalaya Ltd?

The Face Value of Narayana Hrudayalaya Ltd is 10.0.